Table 4.
Summary of antimicrobial resistance results in Enterococcus spp. isolated from poultry published in the last 5 years, within the five continents.
| Study | Region | Reference | Publishing year | No. of isolates | Resistance profile (%) |
|---|---|---|---|---|---|
| 1 | Africa | Ngbede et al. | 2016 | 53 | AMP (43,4), C (9,4), CIP (11,3), ERY (73,5), GM (47,1), QD (9,4), RIF (15,1), S (47,1), T (81,1), VAN (0) |
| 2 | North America | Kilonzo-Nthenge et al. | 2015 | 132 | AK (19,7), AMC (10,6), AMP (14,4), AZI (6,8), C (3), CEC (3), ERY (62,9), FOX (7,6), KA (47), P (52,3), S (81,8), T (44,7) |
| 3 | North America | Tyson et al. | 2017 | 5455 | C (0,3), CIP (17,8), DAP (1,9), ERY (28,1), GM (6,6), KA (19,8), LZD (0,1), NIT (24,7), P (13,3), QD (20,5), S (16,6), T (60), TGC (0,1), TYL (27,2), VAN (0) |
| 4 | South America | Donado-Godoy et al. | 2014 | E. faecalis 121 | AMP (0), CIP (32), ERY (86), VAN (2) |
| E. faecium 60 | AMP (0), CIP (33), ERY (62), QD (60), VAN (0) | ||||
| 5 | South America | Cavaco et al. | 2017 | E. faecalis 40 | C (2,5), CIP (2,5), ERY (7,5) FFC (2,5), GM (2,5), KA (2,5), LZD (7,5), S (5), T (7,5), TZD (7,5) |
| 6 | South America | Braga et al. | 2017 | E. faecalis 12 | AMP (0), AMX (0), BAC (0), CEF (8,3), GM (33,3), NEO (25), PNV (0), VAN (8,3) |
| 7 | Asia | Usui et al. | 2014 | E. faecalis 117 | AMP (0), C (27,4), ENR (17,9), ERY (70,9), GM (11,1), KA (37,6), MY (73,5), OT (69,2), S (51,3), VAN (0) |
| 8 | Europe | Maajost et al. | 2015 | E. faecalis 126 | AMC (0), AMP (0), C (8), CIP (5), ERY (44), GM (44), MY (99), P (0), T (82), TYL (44), VAN (0) |
| E. faecium 18 | AMC (17), AMP (28), C (6), CIP (56), ERY (61), GM (72), MY (72), P (44), T (67), TYL (56), VAN (0) | ||||
| 9 | Europe | Stepien-Pysnick | 2016 | 911 | AMC (4), AMX (4,4), DOX (67,3), ENR (69,4), FFC (15,7), MY (56,1), SXT (88), TYL (71,4), VAN (0,1) |
AK amikacin, AMC amoxicillin/clavulanic acid, AMP ampicillin, AMX amoxicillin, AZI azithromycin, BAC bacitracin, C chloramphenicol, CEC cefaclor, CEF ceftiofur, CIP ciprofloxacin, DAP daptomycin, DOX doxycycline, ENR enrofloxacin, ERY erythromycin, FFC florfenicol, FOX cefoxitin, GM gentamicin, KA kanamycin, LZD linezolid, MY lincomycin, NEO neomycin, NIT nitrofurantoin, OT oxytetracycline, P penicillin, PNV penicillin/novobiocin, QD quinupristin/dalfopristin, RIF rifampicin, S streptomycin, SXT sulfamethoxazole/trimethoprim, T tetracycline, TGC tigecycline, TYL tyrosine, TZD tedizolid, VAN vancomycin